Φορτώνει......
Passive immunotherapies targeting amyloid beta and tau oligomers in Alzheimer’s disease
Alzheimer’s disease (AD) is historically difficult to treat, in part due the inaccessible nature of brain pathology. Amyloid-β (Aβ) and tau proteins drive pathology by forming toxic oligomers that eventually deposit as insoluble amyloid plaques and neurofibrillary tangles. Recent clinical studies su...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Pharm Sci |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6937375/ https://ncbi.nlm.nih.gov/pubmed/31647950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2019.10.024 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|